2017 was a year for the record books at the Patent Trials and Appeal Board (PTAB), which has included newly created standard operating procedures from the PTAB, a landmark en banc ruling from the Court of Appeals for the Federal Circuit impacting amendment practice, and a series of informative decisions from PTAB impacting multiple proceedings against the same patent.
Foley attorneys George Beck, Andrew Cheslock, and Steve Maebius together discussed the year's major developments and how they may impact practice before the PTAB going forward in a web seminar, which can be replayed at " PTAB – A Year In Review".
Specific topics included:
- 2017 Trends and Statistics
- SCOTUS on IPRs – including SAS Institute Inc. v. Joseph Matal and Oil States Energy Services LLC v. Greene's Energy Group, LLC
- PTAB Amendment Process – via Aqua Products v. Matal
- Trends in Pharmaceutical IPRs Filed by Generic Petitioners
- PTAB Grants Rare Request for Additional Discovery in Mylan v. Allergan IPR
- Sovereign Immunity
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
